130 related articles for article (PubMed ID: 11972749)
1. Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B2 receptor antagonist peptide Hoe 140.
Kennedy KJ; Orwig KS; Dix TA; Christopher J; Jaffa AA
J Pept Res; 2002 Apr; 59(4):139-48. PubMed ID: 11972749
[TBL] [Abstract][Full Text] [Related]
2. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
4. Characterization of bradykinin receptors in a human osteoblastic cell line.
Brechter AB; Lerner UH
Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
[TBL] [Abstract][Full Text] [Related]
5. Ala scan analogues of HOE 140. Synthesis and biological activities.
Quartara L; Ricci R; Meini S; Patacchini R; Giolitti A; Amadesi S; Rizzi C; Rizzi A; Varani K; Borea PA; Maggi CA; Regoli D
Eur J Med Chem; 2000 Nov; 35(11):1001-10. PubMed ID: 11137228
[TBL] [Abstract][Full Text] [Related]
6. [125I]PIP HOE 140, a high affinity radioligand for bradykinin B2 receptors.
Brenner NJ; Stonesifer GY; Schneck KA; Burns HD; Ransom RW
Life Sci; 1993; 53(25):1879-86. PubMed ID: 8255148
[TBL] [Abstract][Full Text] [Related]
7. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the B2 bradykinin receptor reveal a different pattern of contacts for peptidic agonists and peptidic antagonists.
Jarnagin K; Bhakta S; Zuppan P; Yee C; Ho T; Phan T; Tahilramani R; Pease JH; Miller A; Freedman R
J Biol Chem; 1996 Nov; 271(45):28277-86. PubMed ID: 8910447
[TBL] [Abstract][Full Text] [Related]
9. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
Corrêa CR; Calixto JB
Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
[TBL] [Abstract][Full Text] [Related]
10. Effect of WIN 64338, a B2 bradykinin receptor antagonist on guinea-pig tracheal smooth muscle cells in culture.
Scherrer D; Schmidlin F; Lach E; Da Silva A; Landry Y; Gies JP
Fundam Clin Pharmacol; 1998; 12(2):188-93. PubMed ID: 9565773
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats.
Cloutier F; de Sousa Buck H; Ongali B; Couture R
Br J Pharmacol; 2002 Apr; 135(7):1641-54. PubMed ID: 11934804
[TBL] [Abstract][Full Text] [Related]
12. Antagonists for kinin B1 and B2 receptors in the mouse.
Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE-140.
Daffix I; Amblard M; Bergé G; Dodey P; Pruneau D; Paquet JL; Fouchet C; Franck RM; Defrêne E; Luccarini JM; Bélichard P; Martinez J
J Pept Res; 1998 Jul; 52(1):1-14. PubMed ID: 9716245
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and conformational analysis of the D/L-Tic7 stereoisomers of the bradykinin receptor antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin.
Sawutz DG; Salvino JM; Seoane PR; Douty BD; Houck WT; Bobko MA; Doleman MS; Dolle RE; Wolfe HR
Biochemistry; 1994 Mar; 33(9):2373-9. PubMed ID: 8117696
[TBL] [Abstract][Full Text] [Related]
15. Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.
Rizzi A; Calò G; Amadesi S; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):662-70. PubMed ID: 9402047
[TBL] [Abstract][Full Text] [Related]
16. The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold.
Dziadulewicz EK; Brown MC; Dunstan AR; Lee W; Said NB; Garratt PJ
Bioorg Med Chem Lett; 1999 Feb; 9(3):463-8. PubMed ID: 10091703
[TBL] [Abstract][Full Text] [Related]
17. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
[TBL] [Abstract][Full Text] [Related]
18. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
19. Trabecular meshwork bradykinin receptors: mRNA levels, immunohistochemical visualization, signaling processes pharmacology, and linkage to IOP reduction.
Sharif NA; Katoli P; Kelly CR; Li L; Xu S; Wang Y; Klekar L; Earnest D; Yacoub S; Hamilton G; Jacobson N; Shepard AR; Ellis D
J Ocul Pharmacol Ther; 2014 Feb; 30(1):21-34. PubMed ID: 24236827
[TBL] [Abstract][Full Text] [Related]
20. Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.
Marceau F; Levesque L; Drapeau G; Rioux F; Salvino JM; Wolfe HR; Seoane PR; Sawutz DG
J Pharmacol Exp Ther; 1994 Jun; 269(3):1136-43. PubMed ID: 8014858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
